Tirzepatide, the recently approved medication, is creating considerable buzz within the medical community. It works differently from existing diabetes treatments , targeting multiple receptors involved in glucose regulation and appetite . Initial trials have demonstrated impressive efficacy in reducing blood sugar in individuals with type 2 diabete